{"transactions":[{"id":4636431,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T21:53:41.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":786,"price":21,"value":16506.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."}],"balance_after":13578,"source":{"system":"sec-edgar","filing":"0001919246-26-000129","document":"wk-form4_1791323618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1919246/000191924626000129/wk-form4_1791323618.xml","form_type":"4"}},{"id":713395,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T21:03:38.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":94,"price":27.3604,"value":2571.8776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14364,"source":{"system":"sec-edgar","filing":"0001919246-26-000101","document":"wk-form4_1783458216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000191924626000101/wk-form4_1783458216.xml","form_type":"4"}},{"id":713394,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T21:03:38.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":692,"price":25.9959,"value":17989.1628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $25.58 to $26.24. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14458,"source":{"system":"sec-edgar","filing":"0001919246-26-000101","document":"wk-form4_1783458216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000191924626000101/wk-form4_1783458216.xml","form_type":"4"}},{"id":720726,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:06:02.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 36 equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":6000,"derivative":{"exercise_price":154.84,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-26-079865","document":"tm2619349-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000110465926079865/tm2619349-2_4seq1.xml","form_type":"4"}},{"id":774938,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-18T20:44:36.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":4.6,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":9063},"source":{"system":"sec-edgar","filing":"0001573429-26-000001","document":"form4-05182026_080531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000157342926000001/form4-05182026_080531.xml","form_type":"4"}},{"id":774937,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:44:36.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10491,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Certain of these shares are represented by previously reported restricted stock units (\"RSUs\"). Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2026, by and among Soleno Therapeutics, Inc. (the \"Company\"), Neocrine Biosciences, Inc. (\"Parent\") and Sigma Merger Sub, Inc. (\"Merger Sub\"), on May 18, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding vested and unvested RSU was cancelled and converted into the right to receive an amount equal to $53.00 in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001573429-26-000001","document":"form4-05182026_080531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000157342926000001/form4-05182026_080531.xml","form_type":"4"}},{"id":814227,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T21:02:43.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":371,"price":21.3628,"value":7925.5988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15150,"source":{"system":"sec-edgar","filing":"0001919246-26-000053","document":"wk-form4_1775509361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000191924626000053/wk-form4_1775509361.xml","form_type":"4"}},{"id":814226,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-06T21:02:43.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":415,"price":20.5154,"value":8513.891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15521,"source":{"system":"sec-edgar","filing":"0001919246-26-000053","document":"wk-form4_1775509361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000191924626000053/wk-form4_1775509361.xml","form_type":"4"}},{"id":822541,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:42:47.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":25478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (\"Common Stock\") of Pelthos Therapeutics Inc. (the \"Issuer\"), issuable upon settlement of restricted stock units of the Issuer (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the \"2023 Plan\"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4 filed by the reporting person (the \"Original Form 4\").  This Form 4 amendment (this \"Amendment\") is being filed to amend the Original Form 4 in order to report the grant of such RSUs in Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest as follows: the initial one-third of shares vested on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two years, so long as the reporting person remains in the service of the Issuer on each such anniversary."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest as follows: the initial one-third of shares vested on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two years, so long as the reporting person remains in the service of the Issuer on each such anniversary."}],"balance_after":25478,"source":{"system":"sec-edgar","filing":"0001919246-26-000042","document":"wk-form4a_1775079764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000191924626000042/wk-form4a_1775079764.xml","form_type":"4/A","original_submission_date":"2025-07-07"}},{"id":968002,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-16T22:28:36.000Z","date":"2025-12-16","kind":"gift","planned":false,"acquired":false,"shares":128995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On December 16, 2025, the reporting person transferred 128,995 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The reporting person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the reporting person disclaims beneficial ownership of the shares held by the trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any."}],"balance_after":1188050,"source":{"system":"sec-edgar","filing":"0001193125-25-321185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525321185/ownership.xml","form_type":"4"}},{"id":968001,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-16T22:28:36.000Z","date":"2025-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":195705,"price":6.92,"value":1354278.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units."}],"balance_after":1317045,"source":{"system":"sec-edgar","filing":"0001193125-25-321185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525321185/ownership.xml","form_type":"4"}},{"id":970749,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-12T22:01:02.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":false,"shares":2123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":14862,"derivative":{"underlying":"Common Stock","underlying_shares":2123},"source":{"system":"sec-edgar","filing":"0001753926-25-001884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001884/ownership.xml","form_type":"4"}},{"id":970748,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-12T22:01:02.000Z","date":"2025-07-02","kind":"exercise","planned":false,"acquired":false,"shares":8493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":16985,"derivative":{"underlying":"Common Stock","underlying_shares":8493},"source":{"system":"sec-edgar","filing":"0001753926-25-001884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001884/ownership.xml","form_type":"4"}},{"id":970747,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:01:02.000Z","date":"2025-12-10","kind":"gift","planned":false,"acquired":false,"shares":9542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any."}],"balance_after":1074,"source":{"system":"sec-edgar","filing":"0001753926-25-001884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001884/ownership.xml","form_type":"4"}},{"id":970746,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:01:02.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":true,"shares":2123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":10616,"source":{"system":"sec-edgar","filing":"0001753926-25-001884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001884/ownership.xml","form_type":"4"}},{"id":970745,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:01:02.000Z","date":"2025-07-02","kind":"exercise","planned":false,"acquired":true,"shares":8493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units (\"RSUs\"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":8493,"source":{"system":"sec-edgar","filing":"0001753926-25-001884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001884/ownership.xml","form_type":"4"}},{"id":972922,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-11T22:44:10.000Z","date":"2025-12-10","kind":"gift","planned":false,"acquired":false,"shares":23629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person made a bona fide gift to The Pennington School."}],"balance_after":1512750,"source":{"system":"sec-edgar","filing":"0001193125-25-316295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525316295/ownership.xml","form_type":"4"}},{"id":1091089,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-07-08T01:45:34.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":77640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 2, 2025, the Reporting Person was granted stock options to purchase 77,640 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 2, 2025, the Reporting Person was granted stock options to purchase 77,640 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":77640,"derivative":{"exercise_price":13.5,"exercise_date":"2026-07-02","expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":77640},"source":{"system":"sec-edgar","filing":"0001753926-25-001107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001107/ownership.xml","form_type":"4"}},{"id":1091088,"issuer":{"id":6798,"kind":"organization","name":"Pelthos Therapeutics Inc.","symbol":"PTHS"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-07-08T01:45:34.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":25478,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 25,478 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 25,478 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years."}],"balance_after":25478,"derivative":{"exercise_price":13.5,"exercise_date":"2026-07-02","expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":25478},"source":{"system":"sec-edgar","filing":"0001753926-25-001107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000175392625001107/ownership.xml","form_type":"4"}},{"id":1117834,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T23:21:26.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on the earlier of the twelve-month anniversary of June 5, 2025 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date. The Reporting Person previously elected to defer receipt of the shares of Common Stock underlying RSUs upon vesting. In accordance with the Reporting Person's deferral election the vested shares will be delivered to the Reporting Person when the Reporting Person ceases to provide services to the Issuer or upon a change of control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":10491,"source":{"system":"sec-edgar","filing":"0001415889-25-016358","document":"form4-06092025_110609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000141588925016358/form4-06092025_110609.xml","form_type":"4"}},{"id":1187930,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-31T23:24:33.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":false,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares subject to the Option shall vest on September 15, 2023 and each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date."}],"balance_after":9063,"derivative":{"exercise_price":46.31,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":5937},"source":{"system":"sec-edgar","filing":"0001415889-25-009298","document":"form4-03312025_110330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000141588925009298/form4-03312025_110330.xml","form_type":"4"}},{"id":1187929,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-31T23:24:33.000Z","date":"2025-03-28","kind":"sale","planned":false,"acquired":false,"shares":5937,"price":71.5508,"value":424797.0996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $71.54 to $71.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of these securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001415889-25-009298","document":"form4-03312025_110330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000141588925009298/form4-03312025_110330.xml","form_type":"4"}},{"id":1187928,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-31T23:24:33.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":true,"shares":5937,"price":4.6,"value":27310.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of these securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":12437,"source":{"system":"sec-edgar","filing":"0001415889-25-009298","document":"form4-03312025_110330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000141588925009298/form4-03312025_110330.xml","form_type":"4"}},{"id":1331164,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T22:56:45.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer."}],"balance_after":900000,"derivative":{"exercise_price":3.35,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0000950170-24-136782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136782/ownership.xml","form_type":"4"}},{"id":1331163,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-16T22:56:45.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":54702,"price":3.3057,"value":180828.4014,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy tax liability upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price is a weighted average sales price. The sale prices ranged from $3.28 to $3.34. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1536379,"source":{"system":"sec-edgar","filing":"0000950170-24-136782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136782/ownership.xml","form_type":"4"}},{"id":1331162,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-16T22:56:45.000Z","date":"2024-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":92593,"price":3.21,"value":297223.53,"ownership":{"direct":true},"balance_after":1591081,"source":{"system":"sec-edgar","filing":"0000950170-24-136782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136782/ownership.xml","form_type":"4"}},{"id":1331161,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-12-16T22:56:45.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1683674,"source":{"system":"sec-edgar","filing":"0000950170-24-136782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000095017024136782/ownership.xml","form_type":"4"}},{"id":1484841,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T00:50:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on the earlier of the twelve-month anniversary of June 6, 2024 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date. The Reporting Person previously elected to defer receipt of the shares of Common Stock underlying RSUs upon vesting. In accordance with the Reporting Person's deferral election the vested shares will be delivered to the Reporting Person when the Reporting Person ceases to provide services to the Issuer or upon a change of control of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on the earlier of the twelve-month anniversary of June 6, 2024 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date. The Reporting Person previously elected to defer receipt of the shares of Common Stock underlying RSUs upon vesting. In accordance with the Reporting Person's deferral election the vested shares will be delivered to the Reporting Person when the Reporting Person ceases to provide services to the Issuer or upon a change of control of the Issuer."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001415889-24-016310","document":"form4-06112024_120618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000141588924016310/form4-06112024_120618.xml","form_type":"4"}},{"id":1698128,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-12-29T21:35:37.000Z","date":"2023-12-28","kind":"gift","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person made a bona fide gift to The Pennington School."}],"balance_after":1283674,"source":{"system":"sec-edgar","filing":"0001209191-23-060009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123060009/doc4.xml","form_type":"4"}},{"id":1698127,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-12-29T21:35:37.000Z","date":"2023-12-28","kind":"sale","planned":false,"acquired":false,"shares":84000,"price":4.7131,"value":395900.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax liability upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1302674,"source":{"system":"sec-edgar","filing":"0001209191-23-060009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123060009/doc4.xml","form_type":"4"}},{"id":1709653,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:46:21.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":225000,"derivative":{"exercise_price":4.45,"expiration_date":"2033-12-14","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-23-058850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058850/doc4.xml","form_type":"4"}},{"id":1709652,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T22:46:21.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 14, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1386674,"source":{"system":"sec-edgar","filing":"0001209191-23-058850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058850/doc4.xml","form_type":"4"}},{"id":1709651,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-12-15T22:46:21.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":109680,"price":4.45,"value":488076.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units."}],"balance_after":936674,"source":{"system":"sec-edgar","filing":"0001209191-23-058850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919123058850/doc4.xml","form_type":"4"}},{"id":1805694,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-08-16T20:13:55.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the Option shall vest on September 15, 2023 and each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date."}],"balance_after":15000,"derivative":{"exercise_price":4.6,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-046006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000120919123046006/doc4.xml","form_type":"4"}},{"id":2085366,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-15T21:06:33.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 13, 2022, subject to the reporting person's continued service with the Issuer."}],"balance_after":700000,"derivative":{"exercise_price":1.51,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-22-061411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122061411/doc4.xml","form_type":"4"}},{"id":2085365,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-12-15T21:06:33.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 13, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1046354,"source":{"system":"sec-edgar","filing":"0001209191-22-061411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122061411/doc4.xml","form_type":"4"}},{"id":2454661,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-01-03T21:10:16.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":62318,"price":1.24,"value":77274.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units."}],"balance_after":721354,"source":{"system":"sec-edgar","filing":"0001209191-22-000131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919122000131/doc4.xml","form_type":"4"}},{"id":2473851,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T23:31:07.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer."}],"balance_after":350000,"derivative":{"exercise_price":1.11,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-21-069586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069586/doc4.xml","form_type":"4"}},{"id":2473850,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-12-14T23:31:07.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in full on December 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":783672,"source":{"system":"sec-edgar","filing":"0001209191-21-069586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121069586/doc4.xml","form_type":"4"}},{"id":2481004,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-12-08T19:41:20.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":6500,"price":1.0599,"value":6889.35,"ownership":{"direct":true},"balance_after":383672,"source":{"system":"sec-edgar","filing":"0001209191-21-068494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121068494/doc4.xml","form_type":"4"}},{"id":2489191,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-12-02T17:28:37.000Z","date":"2021-12-02","kind":"purchase","acquired":true,"shares":10000,"price":1.0954,"value":10954.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $1.0925 to $1.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":377172,"source":{"system":"sec-edgar","filing":"0001209191-21-067432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121067432/doc4.xml","form_type":"4"}},{"id":2501215,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T16:42:35.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":2150,"price":1.065,"value":2289.75,"ownership":{"direct":true},"balance_after":367172,"source":{"system":"sec-edgar","filing":"0001209191-21-066036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121066036/doc4.xml","form_type":"4"}},{"id":2501214,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T16:42:35.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":10000,"price":1.11,"value":11100.0,"ownership":{"direct":true},"balance_after":365022,"source":{"system":"sec-edgar","filing":"0001209191-21-066036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121066036/doc4.xml","form_type":"4"}},{"id":2501213,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-11-22T16:42:35.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":10000,"price":1.1,"value":11000.0,"ownership":{"direct":true},"balance_after":355022,"source":{"system":"sec-edgar","filing":"0001209191-21-066036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121066036/doc4.xml","form_type":"4"}},{"id":2598304,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-08-18T20:03:23.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":11900,"price":1.1904,"value":14165.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $1.175 to $1.205. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":345022,"source":{"system":"sec-edgar","filing":"0001209191-21-052200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121052200/doc4.xml","form_type":"4"}},{"id":2598303,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-08-18T20:03:23.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":15000,"price":1.18,"value":17700.0,"ownership":{"direct":true},"balance_after":333122,"source":{"system":"sec-edgar","filing":"0001209191-21-052200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121052200/doc4.xml","form_type":"4"}},{"id":2699318,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-05-24T12:10:25.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":10000,"price":1.6298,"value":16298.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average purchase price. The purchase prices ranged from $1.625 to $1.63. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":318122,"source":{"system":"sec-edgar","filing":"0001209191-21-035163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121035163/doc4.xml","form_type":"4"}},{"id":2745535,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-04-19T18:46:10.000Z","date":"2021-04-19","kind":"purchase","acquired":true,"shares":27400,"price":1.8201,"value":49870.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average purchase price. The purchase prices ranged from $1.79 to $1.88. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":308122,"source":{"system":"sec-edgar","filing":"0001209191-21-027226","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121027226/doc4.xml","form_type":"4"}},{"id":2776437,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-03-23T01:47:57.000Z","date":"2021-03-22","kind":"purchase","acquired":true,"shares":24100,"price":2.0721,"value":49937.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average purchase price. The purchase prices ranged from $2.04 to $2.11. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":280722,"source":{"system":"sec-edgar","filing":"0001209191-21-022485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121022485/doc4.xml","form_type":"4"}},{"id":2839916,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-02-23T14:48:12.000Z","date":"2021-02-22","kind":"purchase","acquired":true,"shares":28700,"price":1.7435,"value":50038.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average purchase price. The purchase prices ranged from $1.73 to $1.80. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":256622,"source":{"system":"sec-edgar","filing":"0001209191-21-013062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919121013062/doc4.xml","form_type":"4"}},{"id":2940502,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T17:34:06.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer."}],"balance_after":500000,"derivative":{"exercise_price":1.23,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-20-063981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919120063981/doc4.xml","form_type":"4"}},{"id":3031566,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T01:45:26.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":898639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest and become exercisable in thirty-six equal installments on each monthly anniversary of September 11, 2020, subject to the reporting person's continued service with the Issuer."}],"balance_after":898639,"derivative":{"exercise_price":1.32,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":898639},"source":{"system":"sec-edgar","filing":"0000899243-20-025225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924320025225/doc4.xml","form_type":"4"}},{"id":3031565,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T01:45:26.000Z","date":"2017-04-27","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The vesting of the restricted stock units (\"RSUs\") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the \"Merger Agreement\") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0000899243-20-025225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924320025225/doc4.xml","form_type":"4"}},{"id":3031564,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-16T01:45:26.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":227272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs that vest in full on the earlier to occur of (i) December 31, 2021 or (ii) the hiring of a permanent Chief Executive Officer of the Issuer, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":227922,"source":{"system":"sec-edgar","filing":"0000899243-20-025225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924320025225/doc4.xml","form_type":"4"}},{"id":3031563,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-16T01:45:26.000Z","date":"2017-04-27","kind":"exercise","acquired":true,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The vesting of the restricted stock units (\"RSUs\") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the \"Merger Agreement\") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings."}],"balance_after":650,"source":{"system":"sec-edgar","filing":"0000899243-20-025225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924320025225/doc4.xml","form_type":"4"}},{"id":3138685,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T20:31:30.000Z","date":"2020-05-20","kind":"disposition_to_issuer","acquired":false,"shares":26953,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Includes unvested time-based restricted stock units representing a contingent right to receive 26,953 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock and derivative securities of Zyla Life Sciences (\"Issuer\") were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2020 (the \"Merger Agreement\"), by and among Issuer, Assertio Holdings, Inc. (\"Parent\"), Assertio Therapeutics, Inc., Alligator Merger Sub, Inc. and Zyla Merger Sub, Inc. (\"Merger Sub\"), pursuant to which each share of the Issuer's common stock issued and outstanding immediately prior to the effective time of the merger of Merger Sub with and into Issuer (the \"Effective Time\") was converted into the right to receive, and became exchangeable for, (1) 2.5 shares of Parent common stock for each share of Issuer's common stock and (2) any cash in lieu of fractional shares of Parent common stock.  Parent common stock had a market value of approximately $0.80 per share at the close of market immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes unvested time-based restricted stock units representing a contingent right to receive 26,953 shares of Issuer common stock upon vesting and settlement of such time-based restricted stock units.  At the Effective Time, all outstanding time-based restricted stock units of Issuer were cancelled and, in exchange therefor, each former holder of any such cancelled restricted stock unit has the right to receive a number of shares of fully vested Parent common stock (rounded to the nearest whole number) equal to the product of (1) 2.5 and (2) the number of shares of Issuer common stock covered by such restricted stock unit."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-064791","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000110465920064791/a4.xml","form_type":"4"}},{"id":3168160,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-28T23:39:55.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":13333,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-20-005215","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005215/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3168159,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T23:39:55.000Z","date":"2020-04-23","kind":"tax_withholding","acquired":false,"shares":1805,"price":1.75,"value":3158.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay taxes applicable to vesting of restricted stock units."}],"balance_after":4862,"source":{"system":"sec-edgar","filing":"0001179110-20-005215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005215/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3168158,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T23:39:55.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":1.75,"value":11667.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001179110-20-005215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005215/edgar.xml","form_type":"4/A","original_submission_date":"2020-04-24"}},{"id":3169968,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-04-24T22:12:38.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":13333,"derivative":{"underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001179110-20-005105","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005105/edgar.xml","form_type":"4"}},{"id":3169967,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T22:12:38.000Z","date":"2020-04-23","kind":"tax_withholding","acquired":false,"shares":952,"price":1.75,"value":1666.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay taxes applicable to vesting of restricted stock units."}],"balance_after":5715,"source":{"system":"sec-edgar","filing":"0001179110-20-005105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005105/edgar.xml","form_type":"4"}},{"id":3169966,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T22:12:38.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":6667,"price":1.75,"value":11667.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 23, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001179110-20-005105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020005105/edgar.xml","form_type":"4"}},{"id":3224115,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-06T01:41:23.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":13620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest the day prior to the Company's annual meeting of stockholders to be held in 2021."}],"balance_after":13620,"source":{"system":"sec-edgar","filing":"0001179110-20-003202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911020003202/edgar.xml","form_type":"4"}},{"id":3331448,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T23:03:34.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":1.59,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-19-030072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924319030072/doc4.xml","form_type":"4"}},{"id":3549893,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-25T00:53:21.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-19-005161","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911019005161/edgar.xml","form_type":"4"}},{"id":3638143,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-22T13:50:16.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in sixteen equal quarterly installments beginning May 20, 2019, provided the Reporting Person is employed by the Issuer on each vesting date."}],"balance_after":400000,"derivative":{"exercise_price":4.67,"expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001179110-19-002283","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911019002283/edgar.xml","form_type":"4"}},{"id":3638142,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2019-02-22T13:50:16.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest in full on February 20, 2021, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":72608,"source":{"system":"sec-edgar","filing":"0001179110-19-002283","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911019002283/edgar.xml","form_type":"4"}},{"id":3730895,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T21:38:48.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":7.33,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-031096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924318031096/doc4.xml","form_type":"4"}},{"id":4026484,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T19:37:33.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":17392,"price":6.6,"value":114787.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units."}],"balance_after":22608,"source":{"system":"sec-edgar","filing":"0001179110-18-003030","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911018003030/edgar.xml","form_type":"4"}},{"id":4073388,"issuer":{"id":131608,"kind":"organization","name":"Strongbridge Biopharma plc","symbol":"SBBP"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-06T21:59:02.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning May 5, 2018, provided employee is employed by the Company on each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":6.65,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001179110-18-001638","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1573429/000117911018001638/edgar.xml","form_type":"4"}},{"id":4303177,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T22:45:57.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of May 25, 2017, subject to the reporting person's continued service with the Issuer."}],"balance_after":3750,"derivative":{"exercise_price":5.13,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000899243-17-014620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000089924317014620/doc4.xml","form_type":"4"}},{"id":4484218,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":31635,"kind":"person","name":"Pauls Matthew","position":1,"cik":"0001573429","reported_name":"Pauls Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-23T22:16:45.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":45535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017)."}],"balance_after":45535,"derivative":{"underlying":"Common Stock","underlying_shares":45535},"source":{"system":"sec-edgar","filing":"0001209191-17-005127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919117005127/doc4.xml","form_type":"4"}}]}